• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶2(MMP2)的(S)-SB-3CT及其环氧乙烷类似物抑制机制的量子力学/分子力学研究

QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

作者信息

Zhou Jia, Tao Peng, Fisher Jed F, Shi Qicun, Mobashery Shahriar, Schlegel H Bernhard

机构信息

Department of Chemistry, Wayne State University, 5101 Cass Ave Detroit, Michigan 48202.

出版信息

J Chem Theory Comput. 2010 Nov 9;6(11):3580-3587. doi: 10.1021/ct100382k.

DOI:10.1021/ct100382k
PMID:21076643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976054/
Abstract

SB-3CT, (4-phenoxyphenylsulfonyl)methylthiirane, is a potent, mechanism-based inhibitor of the gelatinase sub-class of the matrix metalloproteinase (MMP) family of zinc proteases. The gelatinase MMPs are unusual in that there are several examples where both enantiomers of a racemic inhibitor have comparable inhibitory abilities. SB-3CT is one such example. Here, the inhibition mechanism of the MMP2 gelatinase by the (S)-SB-3CT enantiomer and its oxirane analogue is examined computationally, and compared to the mechanism of (R)-SB-3CT. Inhibition of MMP2 by (R)-SB-3CT was shown previously to involve enzyme-catalyzed C-H deprotonation adjacent to the sulfone, with concomitant opening by β-elimination of the sulfur of the three-membered thiirane ring. Similarly to the R enantiomer, (S)-SB-3CT was docked into the active site of MMP2, followed by molecular dynamics simulation to prepare the complex for combined quantum mechanics and molecular mechanics (QM/MM) calculations. QM/MM calculations with B3LYP/6-311+G(d,p) for the QM part (46 atoms) and the AMBER force field for the MM part were used to compare the reaction of (S)-SB-3CT and its oxirane analogue in the active site of MMP2 (9208 atoms). These calculations show that the barrier for the proton abstraction coupled ring opening reaction of (S)-SB-3CT in the MMP2 active site is 4.4 kcal/mol lower than its oxirane analogue, and the ring opening reaction energy of (S)-SB-3CT is only 1.6 kcal/mol less exothermic than its oxirane analogue. Calculations also show that the protonation of the ring-opened products by water is thermodynamically much more favorable for the alkoxide obtained from the oxirane, than for the thiolate obtained from the thiirane. In contrast to (R)-SB-3CT and the R-oxirane analogue, the double bonds of the ring-opened products of (S)-SB-3CT and its S-oxirane analogue have the cis-configuration. Vibrational frequency and intrinsic reaction path calculations on a reduced size QM/MM model (2747 atoms) provide additional insight into the mechanism. These calculations yield 5.9 and 6.7 for the deuterium kinetic isotope effect for C-H bond cleavage in the transition state for the R and S enantiomers of SB-3CT, in good agreement with the experimental results.

摘要

SB - 3CT,即(4 - 苯氧基苯基磺酰基)甲基硫杂环丙烷,是基质金属蛋白酶(MMP)家族锌蛋白酶中明胶酶亚类的一种强效、基于机制的抑制剂。明胶酶MMPs不同寻常之处在于,有几个外消旋抑制剂对映体的例子,其两种对映体都具有相当的抑制能力。SB - 3CT就是这样一个例子。在此,通过计算研究了(S)-SB - 3CT对映体及其环氧乙烷类似物对MMP2明胶酶的抑制机制,并与(R)-SB - 3CT的机制进行了比较。先前已表明(R)-SB - 3CT对MMP2的抑制涉及酶催化的砜相邻位置的C - H去质子化,同时通过β - 消除使三元硫杂环丙烷环的硫原子开环。与R对映体类似,将(S)-SB - 3CT对接至MMP2的活性位点,随后进行分子动力学模拟,为结合量子力学和分子力学(QM/MM)计算准备复合物。使用QM部分(46个原子)的B3LYP/6 - 311 + G(d,p)和MM部分的AMBER力场进行QM/MM计算,以比较(S)-SB - 3CT及其环氧乙烷类似物在MMP2活性位点(9208个原子)中的反应。这些计算表明,(S)-SB - 3CT在MMP2活性位点中质子夺取偶联开环反应的势垒比其环氧乙烷类似物低4.4千卡/摩尔,并且(S)-SB - 3CT的开环反应能量仅比其环氧乙烷类似物少放热1.6千卡/摩尔。计算还表明,水对开环产物的质子化在热力学上对由环氧乙烷得到的醇盐比对由硫杂环丙烷得到的硫醇盐更有利。与(R)-SB - 3CT和R - 环氧乙烷类似物相反,(S)-SB - 3CT及其S - 环氧乙烷类似物的开环产物的双键具有顺式构型。在简化尺寸的QM/MM模型(2747个原子)上进行的振动频率和本征反应路径计算为该机制提供了更多见解。这些计算得出SB - 3CT的R和S对映体在过渡态中C - H键断裂的氘动力学同位素效应分别为5.9和6.7,与实验结果良好吻合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/429f883283a1/nihms244113f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/ab56f0672182/nihms244113f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/f6a89ff09d98/nihms244113f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/01229d40bde7/nihms244113f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/9ae903a79d0c/nihms244113f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/429f883283a1/nihms244113f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/ab56f0672182/nihms244113f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/f6a89ff09d98/nihms244113f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/01229d40bde7/nihms244113f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/9ae903a79d0c/nihms244113f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fb/2976054/429f883283a1/nihms244113f5.jpg

相似文献

1
QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.基质金属蛋白酶2(MMP2)的(S)-SB-3CT及其环氧乙烷类似物抑制机制的量子力学/分子力学研究
J Chem Theory Comput. 2010 Nov 9;6(11):3580-3587. doi: 10.1021/ct100382k.
2
Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.基质金属蛋白酶2抑制作用:(4-苯氧基苯磺酰基)甲基硫杂环丙烷及其环氧乙烷类似物抑制机制的量子力学与分子力学联合研究
Biochemistry. 2009 Oct 20;48(41):9839-47. doi: 10.1021/bi901118r.
3
Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.基质金属蛋白酶2(MMP2)抑制作用:SB - 3CT亚砜类似物去质子化引发的开环反应的密度泛函理论(DFT)和量子力学/分子力学(QM/MM)研究
J Phys Chem B. 2010 Jan 21;114(2):1030-7. doi: 10.1021/jp909327y.
4
DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.基质金属蛋白酶2强效抑制剂SB - 3CT开环机制的密度泛函理论研究
Org Lett. 2009 Jun 18;11(12):2559-62. doi: 10.1021/ol9008393.
5
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.小分子 MMP2/MMP9 抑制剂 SB-3CT 通过调节 PD-L1 来调节肿瘤免疫监视。
Genome Med. 2020 Sep 28;12(1):83. doi: 10.1186/s13073-020-00780-z.
6
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.硫杂环戊烷部分的活性部位开环和明胶酶的皮摩尔抑制作用。
Chem Biol Drug Des. 2009 Dec;74(6):527-34. doi: 10.1111/j.1747-0285.2009.00881.x. Epub 2009 Oct 6.
7
Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.尽管肿瘤坏死因子-α转化酶和基质金属蛋白酶的催化锌位点在结构上高度相似,但其电子和化学性质存在显著差异。
J Biol Chem. 2004 Jul 23;279(30):31646-54. doi: 10.1074/jbc.M401310200. Epub 2004 Apr 21.
8
Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.基质金属蛋白酶-9的选择性抑制可减轻重度创伤性脑损伤所致的继发性损伤。
PLoS One. 2013 Oct 23;8(10):e76904. doi: 10.1371/journal.pone.0076904. eCollection 2013.
9
The MMP2 and MMP9-specific inhibitor SB-3CT significantly decreases blood pressure in pre-eclampsia model rats.基质金属蛋白酶2和基质金属蛋白酶9特异性抑制剂SB - 3CT可显著降低子痫前期模型大鼠的血压。
Biol Reprod. 2025 Jul 13;113(1):209-219. doi: 10.1093/biolre/ioaf075.
10
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.选择性明胶酶抑制剂抑制 MMP-9 对栓塞性局灶性脑缺血的神经血管保护作用。
Mol Neurodegener. 2012 May 15;7:21. doi: 10.1186/1750-1326-7-21.

引用本文的文献

1
New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema.脑水肿的机制和治疗靶点的新见解。
Curr Neuropharmacol. 2024;22(14):2330-2352. doi: 10.2174/1570159X22666240528160237.
2
Metal-ion promiscuity of microbial enzyme DapE at its second metal-binding site.微生物酶DapE在其第二个金属结合位点的金属离子混杂性
J Biol Inorg Chem. 2021 Aug;26(5):569-582. doi: 10.1007/s00775-021-01875-7. Epub 2021 Jul 9.
3
Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies.量子力学/分子力学(QM/MM)研究中蛋白水解酶的作用机制及其抑制作用

本文引用的文献

1
Combining Quantum Mechanics Methods with Molecular Mechanics Methods in ONIOM.在 ONIOM 中将量子力学方法与分子力学方法相结合。
J Chem Theory Comput. 2006 May;2(3):815-26. doi: 10.1021/ct050289g.
2
Transition States in a Protein Environment - ONIOM QM:MM Modeling of Isopenicillin N Synthesis.蛋白质环境中的过渡态——异青霉素N合成的ONIOM QM:MM建模
J Chem Theory Comput. 2009 Jan 13;5(1):222-34. doi: 10.1021/ct800457g.
3
A toolkit to assist ONIOM calculations.一个辅助 ONIOM 计算的工具包。
Int J Mol Sci. 2021 Mar 22;22(6):3232. doi: 10.3390/ijms22063232.
4
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.解析结核分枝杆菌异柠檬酸裂解酶的催化途径。
Sci Rep. 2020 Nov 3;10(1):18925. doi: 10.1038/s41598-020-75799-8.
5
The Prodrug Approach: A Successful Tool for Improving Drug Solubility.前药方法:提高药物溶解度的成功工具。
Molecules. 2015 Dec 29;21(1):42. doi: 10.3390/molecules21010042.
6
Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases.锌指模体调控基质金属蛋白酶活性的研究
J Phys Chem B. 2014 Nov 26;118(47):13505-12. doi: 10.1021/jp5088702. Epub 2014 Nov 14.
7
Comparison of Three Chain-of-States Methods: Nudged Elastic Band and Replica Path with Restraints or Constraints.三种状态链方法的比较:带约束或限制的推挤弹性带法和副本路径法
J Chem Theory Comput. 2012;8(12):5035-5051. doi: 10.1021/ct3006248. Epub 2012 Sep 27.
J Comput Chem. 2010 Sep;31(12):2363-9. doi: 10.1002/jcc.21524.
4
Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.基质金属蛋白酶2(MMP2)抑制作用:SB - 3CT亚砜类似物去质子化引发的开环反应的密度泛函理论(DFT)和量子力学/分子力学(QM/MM)研究
J Phys Chem B. 2010 Jan 21;114(2):1030-7. doi: 10.1021/jp909327y.
5
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.硫杂环戊烷部分的活性部位开环和明胶酶的皮摩尔抑制作用。
Chem Biol Drug Des. 2009 Dec;74(6):527-34. doi: 10.1111/j.1747-0285.2009.00881.x. Epub 2009 Oct 6.
6
Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.基质金属蛋白酶2抑制作用:(4-苯氧基苯磺酰基)甲基硫杂环丙烷及其环氧乙烷类似物抑制机制的量子力学与分子力学联合研究
Biochemistry. 2009 Oct 20;48(41):9839-47. doi: 10.1021/bi901118r.
7
Binding of matrix metalloproteinase inhibitors to extracellular matrix: 3D-QSAR analysis.基质金属蛋白酶抑制剂与细胞外基质的结合:三维定量构效关系分析
Chem Biol Drug Des. 2008 Oct;72(4):237-48. doi: 10.1111/j.1747-0285.2008.00710.x.
8
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.基质金属蛋白酶在神经性疼痛早期和晚期发展中的不同作用。
Nat Med. 2008 Mar;14(3):331-6. doi: 10.1038/nm1723. Epub 2008 Feb 10.
9
Molecular dynamics simulations of the active matrix metalloproteinase-2: positioning of the N-terminal fragment and binding of a small peptide substrate.活性基质金属蛋白酶-2的分子动力学模拟:N端片段的定位及小肽底物的结合
Proteins. 2008 Jul;72(1):50-61. doi: 10.1002/prot.21894.
10
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.基质金属蛋白酶基质溶解素-3在甲状腺激素依赖性胚胎后发育过程中对细胞外基质重塑和细胞命运决定的调控
Pharmacol Ther. 2007 Dec;116(3):391-400. doi: 10.1016/j.pharmthera.2007.07.005. Epub 2007 Aug 31.